Project Grant K99AI186598

Award Date 7/1/24
Completion Date 6/30/26
Dollars Obligated $273K
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21250, USA
Similar Awards
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $132,300.00 to the Regents of the University of Michigan to conduct research on the multifaceted roles of phosphatidylinositol (4,5)-bisphosphate [PI(4,5)P2] in HIV-1 assembly. The key research objectives are to: Elucidate the interplay between Gag multimerization and PI(4,5)P2 enrichment at HIV-1 assembly sites, and...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $220,224 to the University of Chicago to computationally investigate key morphological transitions in the HIV-1 life cycle. The research aims to gain a deeper mechanistic understanding of HIV assembly, maturation, and uncoating processes, with a focus on the roles of viral RNA, host cell factors, and...
This Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), aims to measure and understand the molecular mechanisms of viral nucleocapsid self-assembly and disassembly. The $370,190 award, effective May 10, 2025 through March 31, 2030, will use a combination of quantitative experimental methods, including interferometric scattering microscopy and cryo-electron microscopy, to study...
This Project Grant award of $229,163 from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) supports research on the function of the HIV-1 envelope glycoprotein cytoplasmic tail domain. The goal is to investigate how modifications to the cytoplasmic tail, such as lipidation, impact the trafficking and packaging of the envelope protein into HIV-1 virions, which could enable viral spread in restrictive cell types. The research plan...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, provides $400,125.00 to Meharry Medical College to conduct research on a novel mechanism by which HIV-1 evades the antiviral function of the host protein APOBEC3G. The key objectives are to: 1) Compare APOBEC3G-related mutation profiles in infected cells and viral particles, focusing on key RNA packaging elements, and...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $847,141 to investigate the role of HIV-1 integrase (IN) in virion morphogenesis and target it with novel allosteric integrase inhibitors. The research aims to delineate the sequence and structural features of viral RNA recognized by HIV-1 IN and determine cryo-EM structures of IN tetramers bound to cognate viral RNA...
This federal Project Grant award of $2,505,639 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand the molecular interactions between lentivirus capsids and the nuclear pore complex protein NUP358. The project aims to investigate how the binding of lentiviral capsids, including HIV-1 and HIV-2, to the RBD4-CHD didomain of NUP358 impacts viral nuclear import and replication....
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is focused on determining the mechanism by which the cellular protein EHD4 decreases the infectivity of HIV-1 virus particles. The $238,972 award to The Research Foundation For The State University Of New York (RF SUNY) aims to: 1) Characterize how EHD4 blocks the incorporation of HIV-1 envelope glycoproteins GP41 and GP120...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Program (CFDA 93.855), provides $653,693 to Emory University to conduct research on the structural details of HIV-1 virion assembly, maturation, and entry. The work will leverage cryo-electron microscopy and tomography to interrogate the molecular determinants and cellular interactions involved in the HIV-1 capsid lattice formation and...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $140,733 to The Salk Institute for Biological Studies to conduct structural and biochemical studies on how retroviruses like HIV and MMTV integrate their viral DNA into host chromatin. The research aims to mechanistically interrogate the intasome complex that catalyzes retroviral integration, using novel nucleosome...

RIBONUCLEOPROTEIN COMPLEXES INVOLVED IN THE LATE PHASE OF HIV-1 REPLICATION - PROJECT SUMMARY/ABSTRACT THE OVERALL GOAL OF THIS PROJECT IS TO UNDERSTAND HOW HIV-1 PACKAGES ITS RNA GENOME. DURING VIRUS ASSEMBLY, TWO COPIES OF THE VIRAL RNA ARE TRAFFICKED TO THE PLASMA MEMBRANE AND ANCHORED TO ASSEMBLY SITES BY A SMALL NUMBER OF VIRAL GAG POLYPROTEINS (~24 OR FEWER). THE RESULTING COMPLEX FUNCTIONS AS A NUCLEANT FOR FURTHER VIRUS ASSEMBLY, RECRUITING ADDITIONAL GAG MOLECULES AND PROMOTING BUDDING. ALTHOUGH MECHANISTIC AND ATOMIC LEVEL DETAILS ARE UNKNOWN, STUDIES SUGGEST THAT ASSEMBLY OF THE GAG:RNA COMPLEX IS MEDIATED BY A COMBINATION OF INTERMOLECULAR INTERACTIONS BETWEEN THE CAPSID (CA) DOMAINS OF GAG, AND BETWEEN GAG'S NUCLEOCAPSID DOMAIN (NC) AND AN RNA PACKAGING SIGNAL (PsCES) LOCATED WITHIN THE 5-UNTRANSLATED REGION OF THE GENOME. THE PROPOSED STUDIES AIM TO (I) IDENTIFY THE STRUCTURAL DETERMINANTS AND MECHANISM OF GAG ASSEMBLY ON THE VIRAL RNA PACKAGING SIGNAL DURING DIFFERENT STAGES OF ASSEMBLY (SUPPORTED BY THE K99). ADDITIONALLY, THE PROPOSAL AIMS TO (II) COLLECT MORE STRUCTURAL INFORMATION OF HOST CELL FACTOR INTERACTION, SPECIFICALLY STAUFEN1, WITH THE VIRAL RNA (R00), RAISING POTENTIAL NOVEL TARGET SITES FOR DRUG DEVELOPMENT. THE K99 RESEARCH, CONDUCTED UNDER THE MENTORSHIP OF DR. MICHAEL F. SUMMERS (PRIMARY MENTOR AT UMBC) AND DR. OWEN PORNILLOS (SECONDARY MENTOR AT THE UNIVERSITY OF UTAH), WILL EMPLOY AN INTEGRATED STRUCTURAL BIOLOGY APPROACH, WHERE ISOTOPE-EDITED NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY (NMR) WILL BE USED TO DETERMINE KEY INTERMOLECULAR GAG:GAG AND GAG:RNA INTERACTIONS THAT PROMOTE ASSEMBLY, AND CRYOGENIC ELECTRON MICROSCOPY TO VISUALIZE ATOMIC-LEVEL DETAILS OF THE GAG:RNA COMPLEX THAT NUCLEATES VIRUS ASSEMBLY. MECHANISTIC HYPOTHESES WILL BE TESTED BY IN-CELL STUDIES UNDER THE GUIDANCE OF VIROLOGIST DR. ALICE TELESNITSKY (MEMBER OF THE ADVISORY COMMITTEE AT UNIVERSITY OF MICHIGAN). EXPERTISE DEVELOPED IN NMR, CRYOGENIC ELECTRON MICROSCOPY, AND CELLULAR TECHNIQUES WILL PREPARE ME FOR AN INDEPENDENT CAREER TO WORK WITHIN THE BROADER AREA OF HOST-VIRUS RNP INTERACTIONS. OVERALL, THESE STUDIES WILL PROVIDE THE FIRST STRUCTURAL AND MECHANISTIC INSIGHTS FOR THE RIBONUCLEOPROTEIN COMPLEX THAT NUCLEATES HIV-1 ASSEMBLY AND ITS INTERACTIONS WITH ESSENTIAL HOST FACTORS AND WILL PROVIDE DR. HOLLMANN SKILLS TO ESTABLISH AN INDEPENDENT AND INCLUSIVE RESEARCH PROGRAM.

Posted 6/26/24, 12:00 AM